Development of a Scalable Synthesis of Casdatifan (AB521), a Potent, Selective, Clinical-Stage Inhibitor of HIF-2α
Organic Process Research & Development, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 5, 2025
Language: Английский